HARBINGER STRATEGIES, LLC

Lobbying for MERCK & CO., INC. · Pharmaceutical Company.

Filing 4th Quarter - Termination

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Taxation/Internal Revenue Code

Issues related to international tax policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem